title: Management of primary idiopathic hyperphosphatasemia with calcitonin: a case report.
abstract: We describe a patient with primary idiopathic hyperphosphatasemia, a rare hereditary disease caused by a primary enzymatic disorder. The clinical, radiological, histological and biochemical features of the disease and their response to treatment with Calcitonin are described. We recommend Calcitonin for this rare disease in specialist units. It leads to improvement in many markers and better function.
authors.affiliation: Orthopädische Universitätsklinik am Rudolf-Elle-Krankenhaus Eisenberg, Eisenberg/Thüringen, Germany.
authors.forename: A J
authors.initials: AJ
authors.lastname: Roth
authors.forename: K
authors.initials: K
authors.lastname: Abendroth
authors.forename: J
authors.initials: J
authors.lastname: Seidel
authors.forename: H
authors.initials: H
authors.lastname: Neubert
authors.forename: R
authors.initials: R
authors.lastname: Venbrocks
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood*; D002116:Calcitonin / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008661:Metabolism, Inborn Errors / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D002116:Calcitonin; D000469:Alkaline Phosphatase